Position in ABBV
as of Jun 30, 2026
· filed Jul 8, 2026
Position Value
$19,539,342
+$3,460,959 QoQ
Shares Held
77,648
+5.0% QoQ
Ownership
0.004%
of shares outstanding
% of Portfolio
0.55%
of 13F equity value
Holder Rank
#619
of 4,153 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Gradient Investments LLC holds $135,016,826 across 9 Drug Manufacturers - General names. ABBV ranks #4 (14.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
152,831 | $38,814,489 | |
| 2 | LLY |
ELI LILLY & Co
|
27,342 | $32,794,817 | |
| 3 | AZN |
Astrazeneca PLC
|
108,133 | $20,504,179 | |
| 4 | ABBV |
AbbVie Inc.
This page
|
77,648 | $19,539,342 | |
| 5 | AMGN |
Amgen Inc
|
45,254 | $16,387,378 | |
| 6 | NVS |
Novartis AG
|
37,294 | $5,844,715 | |
| 7 | MRK |
Merck & Co., Inc.
|
3,723 | $478,405 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
5,854 | $337,307 |
All Filings in ABBV
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $19,539,342 | 77,648 | Shares | Sole | 2026-07-08 | |
| 2026-03-31 | $16,078,383 | 73,927 | Shares | Sole | 2026-04-13 | |
| 2025-12-31 | $16,257,291 | 71,151 | Shares | Sole | 2026-01-08 | |
| 2025-09-30 | $17,800,100 | 76,877 | Shares | Sole | 2025-10-06 | |
| 2025-06-30 | $15,556,812 | 83,810 | Shares | Sole | 2025-07-08 | |
| 2025-03-31 | $16,644,478 | 79,441 | Shares | Sole | 2025-04-09 | |
| 2024-12-31 | $15,186,064 | 85,459 | Shares | Sole | 2025-01-21 | |
| 2024-09-30 | $15,317,536 | 77,565 | Shares | Sole | 2024-10-15 | |
| 2024-06-30 | $16,329,904 | 95,207 | Shares | Sole | 2024-07-18 | |
| 2024-03-31 | $17,096,822 | 93,887 | Shares | Sole | 2024-04-23 | |
| 2023-12-31 | $1,462,761 | 9,439 | Shares | Sole | 2024-01-18 | |
| 2023-09-30 | $1,420,988 | 9,533 | Shares | Sole | 2023-10-27 | |
| 2023-06-30 | $1,541,580 | 11,442 | Shares | Sole | 2023-07-11 | |
| 2023-03-31 | $2,454,298 | 15,400 | Shares | Sole | 2023-04-17 | |
| 2022-12-31 | $2,484,107 | 15,371 | Shares | Sole | 2023-01-10 | |
| 2022-09-30 | $2,061,465 | 15,360 | Shares | Sole | 2022-10-14 | |
| 2022-06-30 | $2,322,518 | 15,164 | Shares | Sole | 2022-07-11 | |
| 2022-03-31 | $2,307,473 | 14,234 | Shares | Sole | 2022-05-26 | |
| 2021-12-31 | $1,968,309 | 14,537 | Shares | Sole | 2022-01-12 | |
| 2021-09-30 | $915,276 | 8,485 | Shares | Sole | 2021-10-18 | |
| 2021-06-30 | $12,141,240 | 107,788 | Shares | Sole | 2021-07-12 | |
| 2021-03-31 | $11,335,503 | 104,745 | Shares | Sole | 2021-04-21 | |
| 2020-12-31 | $11,223,641 | 104,747 | Shares | Sole | 2021-01-08 | |
| 2020-09-30 | $9,286,554 | 106,023 | Shares | Sole | 2020-10-06 | |
| 2020-06-30 | $10,657,733 | 108,553 | Shares | Sole | 2020-07-10 | |
| 2020-03-31 | $8,762,916 | 115,014 | Shares | Sole | 2020-04-07 | |
| No filing history on record for this holder in this stock. | ||||||